ResearchMoz added Latest Research Report titled " Neuropathic Pain - Pipeline Review, H2 2016 " to it's Large Report database.
Neuropathic Pain - Pipeline Review, H2 2016
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain Pipeline Review, H2 2016, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.
Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many other diseases. The symptoms might include shooting pain and numbness. Several factors are involved in causing neuropathic pain however there seems to be no specific reason. Trauma, kidney disease, alcoholism, infections, stress etc may lead to painful symptoms. The condition may be controlled by the use of medications and psychological therapies.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=905717
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Neuropathic Pain Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Neuropathic Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Neuropathic Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Neuropathic Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, Preclinical, Discovery and Unknown stages are 1, 6, 27, 29, 1, 119, 21 and 3 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 37 and 1 molecules, respectively.
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Contents
Table of Contents 2
Introduction 8
Neuropathic Pain Overview 9
Therapeutics Development 10
Neuropathic Pain - Therapeutics under Development by Companies 12
Neuropathic Pain - Therapeutics under Investigation by Universities/Institutes 22
Neuropathic Pain - Pipeline Products Glance 24
Neuropathic Pain - Products under Development by Companies 28
Neuropathic Pain - Products under Investigation by Universities/Institutes 42
Neuropathic Pain - Companies Involved in Therapeutics Development 44
Neuropathic Pain - Therapeutics Assessment 165
Drug Profiles 188
Neuropathic Pain - Dormant Projects 491
Neuropathic Pain - Discontinued Products 516
Neuropathic Pain - Product Development Milestones 524
Appendix 534
List of Tables
Number of Products under Development for Neuropathic Pain, H2 2016 36
Number of Products under Development for Neuropathic Pain - Comparative Analysis, H2 2016 37
Number of Products under Development by Companies, H2 2016 38
Number of Products under Development by Companies, H2 2016 (Contd..1) 39
Number of Products under Development by Companies, H2 2016 (Contd..2) 40
Number of Products under Development by Companies, H2 2016 (Contd..3) 41
Number of Products under Development by Companies, H2 2016 (Contd..4) 42
Number of Products under Development by Companies, H2 2016 (Contd..5) 43
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Neuropathic Pain - Pipeline Review, H2 2016
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain Pipeline Review, H2 2016, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.
Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many other diseases. The symptoms might include shooting pain and numbness. Several factors are involved in causing neuropathic pain however there seems to be no specific reason. Trauma, kidney disease, alcoholism, infections, stress etc may lead to painful symptoms. The condition may be controlled by the use of medications and psychological therapies.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=905717
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Neuropathic Pain Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Neuropathic Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Neuropathic Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Neuropathic Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, Preclinical, Discovery and Unknown stages are 1, 6, 27, 29, 1, 119, 21 and 3 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 37 and 1 molecules, respectively.
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Contents
Table of Contents 2
Introduction 8
Neuropathic Pain Overview 9
Therapeutics Development 10
Neuropathic Pain - Therapeutics under Development by Companies 12
Neuropathic Pain - Therapeutics under Investigation by Universities/Institutes 22
Neuropathic Pain - Pipeline Products Glance 24
Neuropathic Pain - Products under Development by Companies 28
Neuropathic Pain - Products under Investigation by Universities/Institutes 42
Neuropathic Pain - Companies Involved in Therapeutics Development 44
Neuropathic Pain - Therapeutics Assessment 165
Drug Profiles 188
Neuropathic Pain - Dormant Projects 491
Neuropathic Pain - Discontinued Products 516
Neuropathic Pain - Product Development Milestones 524
Appendix 534
List of Tables
Number of Products under Development for Neuropathic Pain, H2 2016 36
Number of Products under Development for Neuropathic Pain - Comparative Analysis, H2 2016 37
Number of Products under Development by Companies, H2 2016 38
Number of Products under Development by Companies, H2 2016 (Contd..1) 39
Number of Products under Development by Companies, H2 2016 (Contd..2) 40
Number of Products under Development by Companies, H2 2016 (Contd..3) 41
Number of Products under Development by Companies, H2 2016 (Contd..4) 42
Number of Products under Development by Companies, H2 2016 (Contd..5) 43
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
No comments:
Post a Comment